Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
filingDate |
1990-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b1b2c005b0858a1d5d87eada4c00ce1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9419fe04fac301bd217d1179886bf458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d161f75c059cadc96666d160c599ed91 |
publicationDate |
1991-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0443028-A1 |
titleOfInvention |
Non-injection carcinostatic agent for suppressing occurrence of inflammation due to 5-fluorouracil and method for curing cancer |
abstract |
This invention provides a non-injection carcinostatic agent containing a 5-fluorouracil and an oxonic acid or a pharmacologically acceptable salt thereof as the active ingredients adapted for use in suppressing the occurrence of inflammation due to the 5-fluorouracil and a method for curing cancer while suppressing the occurrence of such inflammation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0543015-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0543015-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5525603-A |
priorityDate |
1989-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |